Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia. (Q54113253)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

0 references

1 reference

based on heuristic

inferred from title

Daniel Catovsky

2

object named as

Catovsky D

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

author name string

Johnson SA

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Child JA

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Newland AC

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Milligan DW

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Janmohamed R

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

16

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

155-160

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deoxycoformycin in the treatment of mature B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose deoxycoformycin in lymphoid malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and analysis of phase I clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious and immunosuppressive complications of purine analog therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotoxicity of purine analogs: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of deoxycoformycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

https://pubmed.ncbi.nlm.nih.gov/9848579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006100900082

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9848579

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54113253&oldid=2212367530"